Nahdi Medical Company (4164.SR) SAU
96.65
-0.2(-0.21%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
96.65
-0.2(-0.21%)
Currency In SAR
| Market Cap | 12.35B |
| Enterprise Value | 13.58B |
| P/E Ratio | 15.51 |
| PEG Ratio | -4.02 |
| Price/Sales Ratio | 1.21 |
| Price/Book Ratio | 4.81 |
| Enterprise/Revenue | 1.27 |
| Enterprise/EBITDA | 7.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.09 |
| Return On Assets | 0.11 |
| Return On Equity | 0.31 |
| Revenue | 10.21B |
| Revenue/Share | 79.65 |
| Gross Profit | 3.81B |
| EBITDA | 1.69B |
| Net Income | 830.7M |
| Diluted EPS | 6.39 |
| Total Cash | 1.22B |
| Total Cash/Share | 9.34 |
| Total Debt | 1.77B |
| Total Debt/Equity | 0.68 |
| Current Ratio | 1.34 |
| Book Value Per Share | 20.09 |
| 52-Week Change | -23.42 |
| 52-Week High | 132.1 |
| 52-Week Low | 91 |
| Moving Average 50 Days | 102.89 |
| Moving Average 200 Days | 104.79 |
| Average Volume | 154,281 |
| Shares Outstanding | 130M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 5.6 |
| Trailing Annual Dividend Yield | 5.79 |
| Payout Ratio | 0.42 |
| Last Split Factor | N/A |
| Last Split Date | N/A |